indobufen has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dedov, II; Milen'kaia, TM; Shestakova, MV; Tokmakova, AIu; Vykhristiuk, SG | 1 |
| Calacoci, S; Landini, G; Marino, N; Poggiali, C; Rosselli, A | 1 |
1 trial(s) available for indobufen and Chronic Disease
| Article | Year |
|---|---|
[Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Drug Evaluation; Humans; Isoindoles; Leg; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Random Allocation | 1989 |
1 other study(ies) available for indobufen and Chronic Disease
| Article | Year |
|---|---|
[The thromboxane-synthesis inhibitor Ibustrin in the treatment of diabetic angiopathies].
Topics: Adolescent; Adult; Blood Coagulation; Chronic Disease; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Drug Evaluation; Foot; Humans; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane A2 | 1996 |